170 related articles for article (PubMed ID: 12542398)
1. A peptide mimetic of human interferon (IFN)-beta.
Sato A; Sone S
Biochem J; 2003 Apr; 371(Pt 2):603-8. PubMed ID: 12542398
[TBL] [Abstract][Full Text] [Related]
2. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
3. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
4. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
6. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.
Runkel L; De Dios C; Karpusas M; Baker D; Li Z; Zafari M; Betzenhauser M; Muldowney C; Miller S; Redlich PN; Grossberg SE; Whitty A; Hochman PS
J Interferon Cytokine Res; 2001 Nov; 21(11):931-41. PubMed ID: 11747625
[TBL] [Abstract][Full Text] [Related]
7. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
8. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.
Runkel L; deDios C; Karpusas M; Betzenhauser M; Muldowney C; Zafari M; Benjamin CD; Miller S; Hochman PS; Whitty A
Biochemistry; 2000 Mar; 39(10):2538-51. PubMed ID: 10704203
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation of murine IFN-beta in a putative receptor-binding region.
Sommereyns C; Michiels T
J Interferon Cytokine Res; 2006 Jun; 26(6):406-13. PubMed ID: 16734561
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
11. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action.
Pfeffer LM; Basu L; Pfeffer SR; Yang CH; Murti A; Russell-Harde D; Croze E
J Biol Chem; 1997 Apr; 272(17):11002-5. PubMed ID: 9110990
[TBL] [Abstract][Full Text] [Related]
12. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of autocrine interferon-beta requires the presence of a functional interferon type I receptor.
Rousseau V; Cremer I; Lauret E; Rivière I; Aguet M; De Maeyer E
J Interferon Cytokine Res; 1995 Sep; 15(9):785-9. PubMed ID: 8536106
[TBL] [Abstract][Full Text] [Related]
14. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
15. Identification of antiviral mimetic peptides with interferon alpha-2b-like activity from a random peptide library using a novel functional biopanning method.
Zhang Q; Bai G; Chen JQ; Tian W; Cao Y; Pan PW; Wang C
Acta Pharmacol Sin; 2008 May; 29(5):634-40. PubMed ID: 18430373
[TBL] [Abstract][Full Text] [Related]
16. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.
Severa M; Remoli ME; Giacomini E; Ragimbeau J; Lande R; Uzé G; Pellegrini S; Coccia EM
J Leukoc Biol; 2006 Jun; 79(6):1286-94. PubMed ID: 16624932
[TBL] [Abstract][Full Text] [Related]
17. Direct signal transduction via functional interferon-alphabeta receptors in CD34+ hematopoietic stem cells.
Giron-Michel J; Weill D; Bailly G; Legras S; Nardeux PC; Azzarone B; Tovey MG; Eid P
Leukemia; 2002 Jun; 16(6):1135-42. PubMed ID: 12040445
[TBL] [Abstract][Full Text] [Related]
18. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.
Means RT; Krantz SB
Exp Hematol; 1996 Feb; 24(2):204-8. PubMed ID: 8641342
[TBL] [Abstract][Full Text] [Related]
20. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
